📰 Prime Editor News
Page 4 - Prime Editor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prime Editor. Real-time updates on events, politics, business and more.
June 21, 2023
Prime Medicine (NYSE:PRME – Get Rating) and MiNK Therapeutics (NASDAQ:INKT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Profitability This table compares Prime Medicine and MiNK Therapeutics’ […]
May 22, 2023
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 63,212 shares of Prime Medicine stock in a transaction on Friday, May 19th. The shares were sold at an average price of $13.88, for a total value of $877,382.56. The sale was disclosed in a legal filing with the Securities & […]
May 19, 2023
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 27,290 shares of the company’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $12.72, for a total transaction of $347,128.80. Following the completion of the sale, the insider now directly owns 10,958,925 […]
May 19, 2023
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 157,952 shares of the company’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $12.74, for a total value of $2,012,308.48. Following the completion of the sale, the insider now owns […]
May 16, 2023
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 27,290 shares of the company’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $12.72, for a total transaction of $347,128.80. Following the completion of the sale, the insider now directly […]
May 16, 2023
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 157,952 shares of the firm’s stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $12.74, for a total transaction of $2,012,308.48. Following the sale, the insider now directly owns 10,800,973 shares in the […]
May 13, 2023
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 100,772 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $14.13, for a total transaction of $1,423,908.36. Following the sale, the insider now owns 11,421,476 shares of […]
May 5, 2023
Shares of Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) were down 4.6% during mid-day trading on Friday . The stock traded as low as $14.26 and last traded at $14.43. Approximately 41,304 shares were traded during trading, a decline of 77% from the average daily volume of 181,909 shares. The stock had previously closed at […]
April 21, 2023
Stifel Nicolaus assumed coverage on shares of Prime Medicine (NYSEARCA:PRME – Get Rating) in a research note released on Monday, The Fly reports. The firm issued a buy rating and a $18.00 price objective on the stock. Separately, Morgan Stanley cut their price target on shares of Prime Medicine from $23.00 to $21.00 and set […]
April 19, 2023
OUP Management Co. LLC bought a new position in shares of Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 121,255 shares of the company’s stock, valued at approximately $2,253,000. Prime Medicine comprises approximately 3.7% of […]